Market Access Views & Analysis

Views & Analysis

Digital health and pharma – adapting to the post-coronavirus...

The need for digital transformation and a response model for coronavirus were among the topics discussed in a recent digital debate

Views & Analysis

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Views & Analysis

6 ways to digitise your business at pace

As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?

Views & Analysis

Coronavirus pharma news roundup 15/5/20

This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.

Views & Analysis

What COVID-19 means for generics companies

Generics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change at all levels of the business.

Views & Analysis

Coronavirus pharma news roundup – 1/5/2020

This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales.

Digital health and pharma – adapting to the post-coronavirus...

Deep Dive: Market Access - Breaking Barriers

6 ways to digitise your business at pace

Coronavirus pharma news roundup 15/5/20

What COVID-19 means for generics companies

Coronavirus pharma news roundup – 1/5/2020

Two more biotechs, Attovia and Braveheart, join the IPO line

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks